Multiple sclerosis therapeutics

✍ Scribed by Rudick, Richard A.; Cohen, Jeffrey Alan

Publisher: Martin Dunitz
Year: 2003
Tongue: English
Leaves: 867
Edition: 2nd ed
Category: Library

No coin nor oath required. For personal study only.

✦ Table of Contents

Content: ""Book Cover""
""Half-Title""
""Title""
""Copyright""
""Contents""
""Contributors""
""Preface to First Edition""
""Preface to Second Edition""
""Acknowledgements""
""I Introduction""
""1 Aspects of multiple sclerosis that relate to clinical trial design and treatment ""
""II Clinical trial methodology""
""2 Measures of neurologic impairment and disability in multiple sclerosis""
""3 Assessment of neuropsychological function in multiple sclerosis""
""4 Health-related quality of life assessment in multiple sclerosis"" ""5 Magnetic resonance imaging in multiple sclerosis: an overview""""6 Measures of gadolinium enhancement in multiple sclerosis ""
""7 Measures of magnetization transfer in multiple sclerosis""
""8 Measures of T1 and T2 relaxation in multiple sclerosis""
""9 Measurement of central nervous system atrophy""
""10 Measures to quantify axonal damage in vivo based on magnetic resonance spectroscopy in multiple sclerosis""
""11 Functional imaging in multiple sclerosis""
""12 Use of cost analyses to improve understanding of the therapeutic trade-offs for multiple sclerosis"" ""13 Ethical considerations in multiple sclerosis clinical trials""""14 The process of drug development and approval in the USA, the European Union, and Canada""
""15 Sponsors, monitoring committees and investigators: the investigatorâ€?s perspective""
""16 Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: reporting extended results from phase III clinical trials""
""17 The failed clinical trial in multiple sclerosis"" ""18 The challenge of long-term studies in multiple sclerosis: use of pooled data, historical controls, and observational studies to determine efficacy""""19 Emerging concepts of pathogenesis: relationship to therapies for multiple sclerosis""
""III Clinical trials of disease-modifying therapy""
""33 Complementary and alternative treatments in multiple sclerosis""
""32 Sex hormones and other pregnancy-related factors with therapeutic potential in multiple sclerosis""
""31 Combination therapies in multiple sclerosis""
""30 Emerging disease-modifying therapies for multiple sclerosis"" ""29 Treatment of multiple sclerosis by hematopoietic stem cell transplantation""""28 Cyclophosphamide treatment of multiple sclerosis""
""27 Treatment of multiple sclerosis with methylprednisolone""
""26 Therapeutic plasma exchange for multiple sclerosis""
""25 Intravenous immunoglobulin to treat multiple sclerosis""
""24 Use of mitoxantrone to treat multiple sclerosis""
""23 Glatiramer acetate as therapy for multiple sclerosis""
""22 Biological responses to type I interferons: relationship to therapeutic effects in multiple sclerosis""

✦ Subjects

Multiple sclerosis.;Multiple sclerosis -- Treatment.;Multiple Sclerosis -- therapy.;Clinical Trials -- methods;Magnetic Resonance Imaging.;Multiple Sclerosis -- pathology.;Outcome Assessment (Health Care);HEALTH & FITNESS -- Diseases -- Alzheimer's & Dementia.;MEDICAL -- Neurology.

📜 SIMILAR VOLUMES

Multiple Sclerosis Therapeutics

📁 Multiple Sclerosis Therapeutics

✍ Jeffrey A. Cohen, Richard A. Rudick 📂 Library 📅 2011 🏛 Cambridge University Press 🌐 English

This book comprehensively reviews the current state of clinical trial methods in multiple sclerosis treatment, providing investigators, sponsors and specialists with current knowledge of outcome measures and study designs for disease and symptom management. The status of the rapidly evolving field o

Multiple Sclerosis Therapeutics, Third E

📁 Multiple Sclerosis Therapeutics, Third Edition

✍ Jeffrey A. Cohen, Richard A. Rudick 📂 Library 📅 2007 🌐 English

Multiple Sclerosis Therapeutics, Second

📁 Multiple Sclerosis Therapeutics, Second Edition

✍ Richard A. Rudick, Jeffrey A. Cohen 📂 Library 📅 2002 🌐 English

This revised text examines the most salient aspects of multiple sclerosis that impact clinical trial design, the development of new disease therapies, and, most importantly, patient care. An international team of contributors discusses the clinical course of multiple sclerosis, its clinical heteroge

Therapeutic Claims in Multiple Sclerosis

📁 Therapeutic Claims in Multiple Sclerosis

✍ William A. Sibley M.D., Therapeutic Claims Committee of the International Federa 📂 Library 📅 1988 🏛 Macmillan Education UK 🌐 English

Multiple Sclerosis

📁 Multiple Sclerosis

✍ Jürg Kesselring (editor), Jane Smith (translator) 📂 Library 📅 1997 🏛 Cambridge University Press 🌐 English

This concise, abundantly illustrated text provides a complete overview of multiple sclerosis. By including recent research findings in genetics, immunology and pathophysiology, the authors provide reliable and up-to-date guidance on the epidemiology, diagnosis, prognosis and treatment of MS. Of par

Multiple Sclerosis

📁 Multiple Sclerosis

✍ Lisa Iezzoni 📂 Library 📅 2010 🏛 Greenwood 🌐 English

Multiple sclerosis (MS) is a degenerative, often disabling disease of the central nervous system that affects 250,000 to 400,000 people living in the United States. It generally starts in young adulthood. Written by a professor of medicine who is also personally affected by the disease, Multiple Scl